Shandong Shanda Wit Science and Technology Co Ltd (000915) - Total Liabilities

Latest as of September 2025: CN¥573.21 Million CNY ≈ $83.88 Million USD

Based on the latest financial reports, Shandong Shanda Wit Science and Technology Co Ltd (000915) has total liabilities worth CN¥573.21 Million CNY (≈ $83.88 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Shandong Shanda Wit Science and Technolo (000915) net asset momentum to track the company's year-over-year net asset growth rate.

Shandong Shanda Wit Science and Technology Co Ltd - Total Liabilities Trend (1996–2024)

This chart illustrates how Shandong Shanda Wit Science and Technology Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Shandong Shanda Wit Science and Technolo (000915) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Shandong Shanda Wit Science and Technology Co Ltd Competitors by Total Liabilities

The table below lists competitors of Shandong Shanda Wit Science and Technology Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
Luzerner Kantonalbank AG
LSE:0QNU
UK £60.23 Billion
Shandong Jinjing Science and Technology Stock Co Ltd
SHG:600586
China CN¥3.88 Billion
Nanjing Red Sun Co Ltd
SHE:000525
China CN¥4.14 Billion
Yatharth Hospital & Trauma Care Services Limited
NSE:YATHARTH
India Rs4.74 Billion
Zhejiang Truelove Vogue Co Ltd
SHE:003041
China CN¥1.09 Billion
Guan Chong Bhd
KLSE:5102
Malaysia RM4.82 Billion
Morguard Corporation
TO:MRC
Canada CA$7.15 Billion
Arctech Solar Holding Co Ltd
SHG:688408
China CN¥5.66 Billion

Liability Composition Analysis (1996–2024)

This chart breaks down Shandong Shanda Wit Science and Technology Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Shandong Shanda Wit Science and Technolo worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 7.12 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.20 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.12 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shandong Shanda Wit Science and Technology Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shandong Shanda Wit Science and Technology Co Ltd (1996–2024)

The table below shows the annual total liabilities of Shandong Shanda Wit Science and Technology Co Ltd from 1996 to 2024.

Year Total Liabilities Change
2024-12-31 CN¥518.50 Million
≈ $75.87 Million
-26.10%
2023-12-31 CN¥701.65 Million
≈ $102.67 Million
+11.55%
2022-12-31 CN¥629.03 Million
≈ $92.05 Million
+17.35%
2021-12-31 CN¥536.03 Million
≈ $78.44 Million
-29.44%
2020-12-31 CN¥759.72 Million
≈ $111.17 Million
+29.80%
2019-12-31 CN¥585.32 Million
≈ $85.65 Million
+4.72%
2018-12-31 CN¥558.92 Million
≈ $81.79 Million
+0.46%
2017-12-31 CN¥556.37 Million
≈ $81.41 Million
+4.40%
2016-12-31 CN¥532.89 Million
≈ $77.98 Million
+32.78%
2015-12-31 CN¥401.35 Million
≈ $58.73 Million
-15.04%
2014-12-31 CN¥472.42 Million
≈ $69.13 Million
+9.45%
2013-12-31 CN¥431.63 Million
≈ $63.16 Million
+9.04%
2012-12-31 CN¥395.83 Million
≈ $57.92 Million
+1.41%
2011-12-31 CN¥390.33 Million
≈ $57.12 Million
-20.16%
2010-12-31 CN¥488.86 Million
≈ $71.54 Million
-16.15%
2009-12-31 CN¥582.99 Million
≈ $85.31 Million
-2.32%
2008-12-31 CN¥596.85 Million
≈ $87.34 Million
-0.48%
2007-12-31 CN¥599.73 Million
≈ $87.76 Million
+5.09%
2006-12-31 CN¥570.70 Million
≈ $83.51 Million
-6.24%
2005-12-31 CN¥608.70 Million
≈ $89.07 Million
+36.78%
2004-12-31 CN¥445.01 Million
≈ $65.12 Million
+7.12%
2003-12-31 CN¥415.43 Million
≈ $60.79 Million
+34.86%
2002-12-31 CN¥308.04 Million
≈ $45.08 Million
+29.02%
2001-12-31 CN¥238.76 Million
≈ $34.94 Million
+69.51%
2000-12-31 CN¥140.86 Million
≈ $20.61 Million
+31.26%
1999-12-31 CN¥107.31 Million
≈ $15.70 Million
-7.75%
1998-12-31 CN¥116.33 Million
≈ $17.02 Million
-1.98%
1997-12-31 CN¥118.68 Million
≈ $17.37 Million
+2.51%
1996-12-31 CN¥115.78 Million
≈ $16.94 Million
--

About Shandong Shanda Wit Science and Technology Co Ltd

SHE:000915 China Drug Manufacturers - Specialty & Generic
Market Cap
$880.91 Million
CN¥6.02 Billion CNY
Market Cap Rank
#9414 Global
#2353 in China
Share Price
CN¥25.69
Change (1 day)
-1.38%
52-Week Range
CN¥24.41 - CN¥35.60
All Time High
CN¥45.34
About

Shandong Wit Dyne Health Co.,Ltd. engages in the pharmaceutical business in China. Its medical products include azithromycin granules, licorice zinc granules, compound calcium carbonate, vitamin AD drops, epalrestat tablets, valsartan hydrochlorothiazide gel, roxithromycin, rosiglitazone tartrate tablets, and glimepiride tablets. The company also provides dextran iron granules, oral rehydration s… Read more